Cargando…
Glioblastoma — treatment and obstacles
BACKGROUND: Glioblastoma is the most common and aggressive primary tumor in adults. A narrative review of all the relevant papers known was conducted. MATERIALS AND METHODS: Reviews, clinical trials, and randomized controlled trials published from 1981 through September 2021 and written, or at least...
Autores principales: | Cantidio, Farley Soares, Gil, Gabriel Oliveira Bernardes, Queiroz, Izabella Nobre, Regalin, Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521695/ https://www.ncbi.nlm.nih.gov/pubmed/36196416 http://dx.doi.org/10.5603/RPOR.a2022.0076 |
Ejemplares similares
-
Practical Prediction Model for Ovarian Insufficiency after Radiation
por: Gil, Gabriel Oliveira Bernardes, et al.
Publicado: (2022) -
A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis
por: Gil, Gabriel Oliveira Bernardes, et al.
Publicado: (2023) -
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
por: Cruz, João Victor Roza, et al.
Publicado: (2022) -
Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
por: Dewdney, Brittany, et al.
Publicado: (2022) -
Differentiation therapy for glioblastoma – too many obstacles?
por: Carén, Helena, et al.
Publicado: (2015)